Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors.

Kaptoge S, Di Angelantonio E, Moore C, Walker M, Armitage J, Ouwehand WH, Roberts DJ, Danesh J, Thompson SG; INTERVAL Trial Group.

Lancet Haematol. 2019 Oct;6(10):e510-e520. doi: 10.1016/S2352-3026(19)30106-1. Epub 2019 Aug 2.

2.

Hydrophobic matching of HIV-1 Vpu transmembrane helix-helix interactions is optimized for subcellular location.

Cole GB, Sharpe S.

Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):183022. doi: 10.1016/j.bbamem.2019.07.010. Epub 2019 Jul 11.

PMID:
31302078
3.

Uptake and spread of infectious laryngotracheitis vaccine virus within meat chicken flocks following drinking water vaccination.

Groves PJ, Williamson SL, Sharpe SM, Gerber PF, Gao YK, Hirn TJ, Walkden-Brown SW.

Vaccine. 2019 Aug 14;37(35):5035-5043. doi: 10.1016/j.vaccine.2019.06.087. Epub 2019 Jul 9.

PMID:
31300291
4.

Sequence variants of human tropoelastin affecting assembly, structural characteristics and functional properties of polymeric elastin in health and disease.

Reichheld SE, Muiznieks LD, Lu R, Sharpe S, Keeley FW.

Matrix Biol. 2019 Jun 26. pii: S0945-053X(19)30160-X. doi: 10.1016/j.matbio.2019.06.010. [Epub ahead of print] Review.

PMID:
31254613
5.

Cross-Linked Elastin-like Polypeptide Membranes as a Model for Medial Arterial Calcification.

Gourgas O, Muiznieks LD, Bello DG, Nanci A, Sharpe S, Cerruti M.

Biomacromolecules. 2019 Jul 8;20(7):2625-2636. doi: 10.1021/acs.biomac.9b00417. Epub 2019 Jun 21.

PMID:
31244014
6.

Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability.

Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM.

J Med Chem. 2019 Jul 11;62(13):6276-6286. doi: 10.1021/acs.jmedchem.9b00657. Epub 2019 Jul 1.

PMID:
31194548
7.

Hawthorne effect in the YourCall trial suggested by participants' qualitative responses.

Sharpe S, Kool B, Whittaker R, Ameratunga S.

J Clin Epidemiol. 2019 Jun 3. pii: S0895-4356(19)30305-1. doi: 10.1016/j.jclinepi.2019.05.035. [Epub ahead of print] No abstract available.

PMID:
31170514
8.

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.

Al-Shahi Salman R, Minks DP, Mitra D, Rodrigues MA, Bhatnagar P, du Plessis JC, Joshi Y, Dennis MS, Murray GD, Newby DE, Sandercock PAG, Sprigg N, Stephen J, Sudlow CLM, Werring DJ, Whiteley WN, Wardlaw JM, White PM; RESTART Collaboration.

Lancet Neurol. 2019 Jul;18(7):643-652. doi: 10.1016/S1474-4422(19)30184-X. Epub 2019 May 22.

9.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.

RESTART Collaboration.

Lancet. 2019 Jun 29;393(10191):2613-2623. doi: 10.1016/S0140-6736(19)30840-2. Epub 2019 May 22.

10.

Early Sedation with Dexmedetomidine in Critically Ill Patients.

Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, Bin Kadiman S, McArthur CJ, Murray L, Reade MC, Seppelt IM, Takala J, Wise MP, Webb SA; ANZICS Clinical Trials Group and the SPICE III Investigators.

N Engl J Med. 2019 Jun 27;380(26):2506-2517. doi: 10.1056/NEJMoa1904710. Epub 2019 May 19.

PMID:
31112380
11.

Effect of a text message intervention on alcohol-related harms and behaviours: secondary outcomes of a randomised controlled trial.

Sharpe S, Kool B, Whittaker R, Lee AC, Reid P, Civil I, Ameratunga S.

BMC Res Notes. 2019 May 14;12(1):267. doi: 10.1186/s13104-019-4308-y.

12.

Genome Organization of Canada Goose Coronavirus, A Novel Species Identified in a Mass Die-off of Canada Geese.

Papineau A, Berhane Y, Wylie TN, Wylie KM, Sharpe S, Lung O.

Sci Rep. 2019 Apr 11;9(1):5954. doi: 10.1038/s41598-019-42355-y.

13.

Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.

Tanner R, O'Shea MK, White AD, Müller J, Harrington-Kandt R, Matsumiya M, Dennis MJ, Parizotto EA, Harris S, Stylianou E, Naranbhai V, Bettencourt P, Drakesmith H, Sharpe S, Fletcher HA, McShane H.

Sci Rep. 2019 Apr 3;9(1):5596. doi: 10.1038/s41598-019-41387-8.

14.

Emergence of Neisseria gonorrhoeae Strains Harboring a Novel Combination of Azithromycin-Attenuating Mutations.

Pham CD, Sharpe S, Schlanger K, St Cyr S, Holderman J, Steece R, Soge OO, Masinde G, Arno J, Schmerer M, Kersh EN; SURRG Working Group.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02313-18. doi: 10.1128/AAC.02313-18. Print 2019 Apr.

15.

Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques.

Sibley L, Gooch K, Wareham A, Gray S, Chancellor A, Dowall S, Bate S, Marriott A, Dennis M, White AD, Marsh PD, Fletcher H, Sharpe S.

Sci Rep. 2019 Mar 4;9(1):3340. doi: 10.1038/s41598-019-39819-6.

16.

Using Exploratory Trials to Identify Relevant Contexts and Mechanisms in Complex Electronic Health Interventions: Evaluating the Electronic Patient-Reported Outcome Tool.

Steele Gray C, Gravesande J, Hans PK, Nie JX, Sharpe S, Loganathan M, Lyons R, Cott C.

JMIR Form Res. 2019 Feb 27;3(1):e11950. doi: 10.2196/11950.

17.

Family reflections: Prematurity-practitioner influence on the lived experience of the parenting role.

Sharpe S.

Pediatr Res. 2019 Aug;86(2):283-284. doi: 10.1038/s41390-019-0351-6. Epub 2019 Feb 21. No abstract available.

PMID:
30791042
18.

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer.

Costa R, Zaman S, Sharpe S, Helenowski I, Shaw C, Han H, Soliman H, Czerniecki B.

Drug Des Devel Ther. 2019 Jan 14;13:309-316. doi: 10.2147/DDDT.S188925. eCollection 2019. Review.

19.

Detection of broadleaf weeds growing in turfgrass with convolutional neural networks.

Yu J, Sharpe SM, Schumann AW, Boyd NS.

Pest Manag Sci. 2019 Aug;75(8):2211-2218. doi: 10.1002/ps.5349. Epub 2019 Mar 8.

PMID:
30672096
20.

In vitro activity of EDTA and TOL-463 against Neisseria gonorrhoeae.

Nash EE, Henning TC, Pham CD, Pettus K, Sharpe S, Kersh EN.

Diagn Microbiol Infect Dis. 2019 Apr;93(4):369-371. doi: 10.1016/j.diagmicrobio.2018.10.021. Epub 2018 Nov 10.

PMID:
30552033

Supplemental Content

Loading ...
Support Center